|
Published
Articles
|
|
|
| |
Differential sensitivity of von Willebrand factor ‘activity’ assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen binding and monoclonal antibody based assays. |
|
| |
Favaloro EJ, Bonar R, Chapman K, Meiring M, Funk (Adcock) D - Journal of Thrombosis and Haemostasis (In press) -
|
|
| |
Red cell folate assays: some answers to current problems with radioassay variability. Pathology 1990;22: 82-87. |
|
| |
Brown RD, Jun R, Hughes W, Watman R, Arnold B, Kronenberg H
|
|
| |
Published: 1990 |
|
| |
Laboratory testing, diagnosis and management of von Willebrand's disease: Current practice in Australasia. American Journal of Clinical Pathology, 1999; 112:712-719. |
|
| |
Favaloro EJ, Smith J, Petinos P, Collecutt M, Street A, Hertzberg M, (on behalf of the RCPA Quality Assurance Program (QAP) in Haematology Scientific Haemostasis Advisory Panel).
|
|
| |
Published: 1999 |
|
| |
Laboratory testing for von Willebrand's disease: An assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thrombosis & Haemostasis, 1999; 82:1276-1282. |
|
| |
Favaloro EJ, Smith J, Petinos P, Hertzberg M, Koutts J, (on behalf of the RCPA Quality Assurance Program (QAP) in Hematology Scientific Hemostasis Advisory Panel).
|
|
| |
Published: 1999 |
|
| |
Laboratory diagnosis of von Willebrand Disorder: Current practice in the Southern Hemisphere. American Journal of Clinical Pathology, 2003; 119:882-893.
|
|
| |
Favaloro EJ, Bonar R, Sioufi J, Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology Haemostasis Committee).
|
|
| |
Published: 2003 |
|
| |
Laboratory diagnosis of von Willebrand Disorder: Quality and diagnostic improvements driven by peer review in a multi-laboratory test process.Haemophilia, 2004, 10; 232?242.
|
|
| |
Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology).
|
|
| |
Published: 2004 |
|
| |
Australasian CD34+ Quality Assurance Program and rationale for the clinical utility of the single platform method for CD34+ cell enumeration |
|
| |
Chang A, Raik E, Marsden K, Ma DDF. Cytotherapy, 2004; 6: 50-61
|
|
| |
Published: 2004 |
|
| |
Laboratory diagnosis of von Willebrand Disorder: Quality and diagnostic improvements driven by peer review in a multi laboratory test process |
|
| |
Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology Haemostasis Committee). Haemophilia 2004; 10:232-242.
|
|
| |
Published: 2004 |
|
| |
External quality assurance of DNA testing for thrombophilia mutations. American Journal of Clinical Pathology, 2005, 123: 189-193. |
|
| |
Hertzberg M, Neville S, Favaloro EJ, MacDonald D.
|
|
| |
Published: 2005 |
|
| |
Multi-laboratory testing of thrombophilia: Current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program in Haematology. Seminars in Thrombosis and Hemostasist, 2005; 31: 49-58.
|
|
| |
Favaloro EJ, Bonar R, Sioufi J, Wheeler M, Low J, Aboud M, Duncan E, Smith J, Exner T, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology).
|
|
| |
Published: 2005 |
|
| |
An international survey of current practice in the laboratory assessment of anticoagulant therapy with heparin. Pathology, 2005; 37: 234-238. |
|
| |
Favaloro EJ, Bonar R, Sioufi J, Wheeler M, Low J, Aboud M, Lloyd J, Street A, Marsden K (on behalf of the RCPA QAP in Haematology).
|
|
| |
Published: 2005 |
|
| |
How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? The laboratory perspective. Laboratory Haematology, 2005;11:157-162. |
|
| |
Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, Lloyd J, Street A, Marsden K (on behalf of the RCPA QAP in Haematology).
|
|
| |
Published: 2005 |
|
| |
Reducing errors in identification of von Willebrand disease: The experience of the Royal College of Pathologists of Australiasia. Seminars in Thrombosis and Hemostasis, 2006; 32: 505-513. |
|
| |
Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Baker R, Hertzberg M, Street A, Marsden K (on behalf of the RCPA QAP in Haematology).
|
|
| |
Published: 2006 |
|
| |
Identification of factor Inhibitors by diagnostic laboratories: A large multi-centre evaluation. Thrombosis and Haemostasis 2006; 96: 73-78. |
|
| |
Favaloro EJ, Bonar R, Earl G, Low J, Aboud M, Duncan E, Just S, Sioufi J, Street A, Marsden K (on behalf of the RCPA QAP in Haematology Haemostasis Committee).
|
|
| |
Published: 2006 |
|
| |
2B or not 2B? Disparite discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2b VWD. |
|
| |
Emmauel J. Favaloror, Roslyn Bonar, Muriel Meiring, Alison Street, Katherine Marsden, on behalf of the RCPA QAP in Haematology.
|
|
| |
Published: 2007 |
|
| |
Emerging Technologies and Quality Assurance in Haemostasis: A review of findings from the Royal College of Pathologists of Australasia (RCPA) Quality Assurance Program. |
|
| |
Favaloro EJ, Bonar R. - Seminars in Thrombosis and Hemostasis - 33: 235-242
|
|
| |
Published: 2007 |
|
| |
Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation. |
|
| |
Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, Just S, Sioufi J, Street A, Marsden K - Pathology - 39: 504-511
|
|
| |
Published: 2007 |
|
| |
The utility of the PFA-100® as a screening test of platelet function: An audit of haemostasis laboratories in Australia and New Zealand. |
|
| |
Favaloro EJ, Bonar R, Duncan E, Rodgers S, Marsden K - Blood Coagulation and Fibrinolysis - 18: 441-448
|
|
| |
Published: 2007 |
|
| |
The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis co-associated with the presence of thrombophilia markers plus mild reduction in von Willebrand factor. |
|
| |
Favaloro EJ, Bonar R, Survela L, McDonald D, Koutts J, Sioufi J, Marsden K - Laboratory Hematology - 13:128-134.
|
|
| |
Published: 2007 |
|
| |
Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification. |
|
| |
Favaloro EJ, Bonar R, Marsden K - Clinical Laboratory Science - 21:178-185
|
|
| |
Published: 2008 |
|
| |
Methodology and Outcomes of Platelet Aggregation Testing in Australia, New Zealand and the Asia-Pacific Region: Results of a Survey from the Royal College of Pathologists of Australasia Haematology Quality Assurance Program. |
|
| |
Duncan EM, Bonar R, Rodgers SE, Favaloro EJ, Marsden K. - International Journal of Laboratory Hematology - 31:398-406
|
|
| |
Published: 2009 |
|
| |
Investigations from External Quality Assurance Programs Reveal a High Degree of Variation in the Laboratory Identification of Coagulation Factor Inhibitors. |
|
| |
Favaloro EJ, Bonar R, Kershaw G, Duncan E, Sioufi J, Marsden K - Semin Thromb Hemost. - 35(8):794-805
|
|
| |
Published: 2009 |
|
| |
Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia. |
|
| |
Favaloro EJ, Bonar R, Kershaw G, Mohammed S, Duncan E, Marsden K - Haemophilia - Jul 1;16(4):662-70
|
|
| |
Published: 2010 |
|
| |
Quality in coagulation and haemostasis testing. |
|
| |
Bonar R, Favaloro EJ, Adcock D - Biochemia Medica - 20(2):184–99
|
|
| |
Published: 2010 |
|
| |
Laboratory investigation of Lupus Anticoagulants: mixing studies are sometimes required. |
|
| |
Favaloro EJ, Bonar R, Zebeljan D, Kershaw G, Marsden K - Journal of Thrombosis and Haemostasis - 8: 2828-31
|
|
| |
Published: 2010 |
|
| |
External quality assurance for the PFA-100. |
|
| |
Favaloro EJ, Bonar R - Journal of Thrombosis and Haemostasis - 9: 878-880
|
|
| |
Published: 2011 |
|
| |
Diagnosis and management of von Willebrand Disease in Australia. |
|
| |
Favaloro EJ, Bonar R, Favaloro, J - Journal of Thrombosis and Haemostasis - 37(5): 542-554
|
|
| |
Published: 2011 |
|
| |
Willebrand factor assay proficiency testing continued. |
|
| |
Favaloro EJ - American Journal of Clinical Patholology - 136(4):657-9
|
|
| |
Published: 2011 |
|
| |
Evaluating laboratory approaches to the identification of lupus anticoagulants: A diagnostic challenge from the RCPA Haematology QAP. |
|
| |
Bonar R, Favaloro EJ - Pathology - April, 44(3), 240-247.
|
|
| |
Published: 2012 |
|
| |
Proficiency testing/External quality assurance for the PFA-100. |
|
| |
Favaloro EJ, Bonar R - Clinical Chemistry Laboratory Medicine. 2012; in press
|
|
| |
Published: 2012 |
|
| |
Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II – Lupus Anticoagulant. |
|
| |
Favaloro EJ, Bonar R, Marsden K. - Seminars in Thrombosis and Hemostasis 2012; 38: in press
|
|
| |
Published: 2012 |
|
| |
|
|
